Urogen Pharma - 53 Year Dividend History | URGN

Historical dividend payout and yield for Urogen Pharma (URGN) since 1971. The current TTM dividend payout for Urogen Pharma (URGN) as of May 24, 2024 is $0.00. The current dividend yield for Urogen Pharma as of May 24, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.311B $0.083B
UroGen Pharma Ltd. is a clinical stage biopharmaceutical company. It focused on developing urological pathologies with a focus on uro-oncology. The company's product candidates include MitoGel and VesiGel which are in clinical trial stage. Its platform technologies include: RTGel and Immunotherapy. UroGen Pharma Ltd. is based in Ra'anana, Israel.
Stock Name Country Market Cap PE Ratio